Precision Bio is taking a novel approach to gene editing to deploy a cure for patients with chronic hepatitis B.
John Parkinson
Advertisement
Articles by John Parkinson
The company plans to use the mRNA platform it harnessed for its COVID-19 vaccine to develop the vaccine for malaria.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
CGTLive®’s Weekly Rewind – October 24, 2025
2
CARsgen’s CAR-T Satri-Cel Significantly Reduces CA19-9 Levels in Patients With Pancreatic Ductal Adenocarcinoma
3
Guess the Therapy Answer October 23, 2025
4
